In the context of resectable NSCLC, treatment with NAC was associated with increased numbers of CD8+CD103+ and CD4+CD103+PD‐1+TIM3− TRM cells in the TME and promoted antitumor immunity.218. The gene discussed is ITGAE; the disease is non-small cell lung carcinoma.